Azitra (AZTR) Other Non Operating Income (2022 - 2026)
Azitra's (AZTR) quarterly Other Non Operating Income came in at -$4624.0 in Q1 2026, down 12.21% YoY from -$5266.9 in Q1 2025, and up 22.31% on a QoQ basis from -$5952.0 in Q4 2025.
Azitra (AZTR) Other Non Operating Income (2022 - 2026) Analysis & Trends
Azitra (AZTR) has 5 years of Other Non Operating Income data on file, last reported at -$4624.0 in Q1 2026.
- Quarterly Other Non Operating Income fell 12.21% year-over-year to -$4624.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$43892.0 (down 354.89% YoY) and the FY2025 annual result came in at -$43389.0, down 388.99% from the prior year.
- Other Non Operating Income rose to -$4624.0 in Q1 2026, from -$5952.0 in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $198234.0 in Q2 2022 to a low of -$47542.0 in Q3 2023.
- A 5-year average of $6975.2 and a median of -$2902.0 in 2023 frame the typical range for Other Non Operating Income.
- Annual changes were most pronounced in 2024 — Other Non Operating Income surged 828.09% — and 2025, when it tumbled 443.04%.
- Tracing AZTR's Other Non Operating Income over 5 years: stood at $20014.0 in 2022, then sank by 102.95% to -$591.0 in 2023, then surged by 828.09% to $4303.0 in 2024, then slumped by 238.32% to -$5952.0 in 2025, then gained by 22.31% to -$4624.0 in 2026.
- The last three Other Non Operating Income figures came in at -$4624.0 (Q1 2026), -$5952.0 (Q4 2025), and -$628.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Azitra | 2.53 Mn | 2.53 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1,788.00 |
| Mar 31, 2026 | -4,624.00 |
| Dec 31, 2025 | -5,952.00 |
| Sep 30, 2025 | -628.00 |
| Jun 30, 2025 | -32,688.00 |
| Mar 31, 2025 | -4,121.00 |
| Dec 31, 2024 | 4,303.00 |
| Sep 30, 2024 | 7,509.00 |
| Jun 30, 2024 | 9,529.00 |
| Mar 31, 2024 | -6,327.00 |
| Dec 31, 2023 | -591.00 |
| Sep 30, 2023 | -47,542.00 |
| Jun 30, 2023 | -1,683.00 |
| Mar 31, 2023 | -4,792.00 |
| Dec 31, 2022 | 20,014.00 |
| Sep 30, 2022 | -19,038.00 |
| Jun 30, 2022 | 198,234.00 |